LEP and obesity due to melanocortin 4 receptor deficiency: Results of these studies will enable a deeper understanding of leptin physiology and possible therapeutic applications as well as prevention of obesity and metabolic disease associated with leptin and leptin receptor heterozygosity or partial leptin deficiency.